SageView Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,249
Closed -$112K 2484
2025
Q4
$112K Buy
+1,249
New +$118K ﹤0.01% 794
2025
Q1
Sell
-2,310
Closed -$244K 624
2024
Q4
$244K Buy
2,310
+300
+15% +$32.2K 0.01% 515
2024
Q3
$217K Sell
2,010
-428
-18% -$46.7K 0.01% 477
2024
Q2
$265K Sell
2,438
-224
-8% -$26.4K 0.01% 463
2024
Q1
$344K Buy
2,662
+39
+1% +$4.87K 0.02% 386
2023
Q4
$321K Buy
+2,623
New +$293K 0.01% 488

Other funds holding ZBH

SageView Advisory Group's ZBH Position: Q1 2026 in Review

SageView Advisory Group sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 1,249 shares — an estimated $112K sold.

SageView Advisory Group first reported a position in ZBH in Q4 2023 and held it in 6 quarters. The position peaked at $344K in Q1 2024. 918 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • SageView Advisory Group reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 1,249 Zimmer Biomet shares in Q1 2026, an estimated $112K.
  • SageView Advisory Group first reported a position in Zimmer Biomet in Q4 2023 and held it in 6 quarters.
  • SageView Advisory Group's Zimmer Biomet position peaked at $344K in Q1 2024.
  • 918 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.